The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AVITA THERAPEUTICS INC COM 05380C102 11,951 474,982 SH   SOLE   212,706 0 262,276
AXONICS MODULATION TECHNOLOG COM 05465P101 6,369 124,787 SH   SOLE   124,787 0 0
BIOHAVEN PHARMACEUTICAL HOLD COM G11196105 2,868 44,112 SH   SOLE   44,112 0 0
MICROSOFT CORP COM 594918104 1,242 5,904 SH   SOLE   5,904 0 0
NICE LTD - SPON ADR SPONSORED ADR 653656108 5,892 25,952 SH   SOLE   5,849 0 20,103
PROFOUND MEDICAL CORP COM NEW 74319B502 3,474 196,924 SH   SOLE   145,740 0 51,184
TAKEDA PHARMACEUTIC-SP ADR SPONSORED ADS 874060205 459 25,723 SH   SOLE   600 0 25,123
WIX.COM LTD SHS M98068105 10,604 41,610 SH   SOLE   10,300 0 31,310